NovaBay Pharma (NBY) Financial Statements

804 Followers

NovaBay Pharma Financial Overview

NovaBay Pharma's market cap is currently $46.33M. The company's EPS TTM is $; its P/E ratio is -1.54; NovaBay Pharma is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 9.78M	$ 10.46M	$ 14.40M	$ 10.20M
Gross Profit	$ -140.00K	$ 6.48M	$ 6.08M	$ 7.78M	$ 6.51M
Operating Income	$ -7.58M	$ -5.84M	$ -4.10M	$ -14.42M	$ -8.86M
EBITDA	$ -7.45M	$ -5.92M	$ -4.09M	$ -7.20M	$ -8.74M
Net Income	$ -22.14M	$ -7.22M	$ -9.64M	$ -10.61M	$ -5.82M
Balance Sheet
Cash & Short-Term Investments	$ 7.96M	$ 430.00K	$ 3.13M	$ 5.36M	$ 7.50M
Total Assets	$ 9.04M	$ 3.42M	$ 9.03M	$ 16.40M	$ 23.98M
Total Debt	$ 776.00K	$ 1.67M	$ 2.74M	$ 2.04M	$ 551.00K
Net Debt	$ -7.18M	$ 1.24M	$ -390.00K	$ -3.32M	$ -6.95M
Total Liabilities	$ 31.86M	$ 3.55M	$ 5.72M	$ 5.84M	$ 13.81M
Stockholders' Equity	$ -22.83M	$ -129.00K	$ 3.31M	$ 10.55M	$ 10.17M
Cash Flow
Free Cash Flow	$ -8.43M	$ -5.19M	$ -4.28M	$ -6.77M	$ -9.24M
Operating Cash Flow	$ -8.43M	$ -5.18M	$ -4.26M	$ -6.65M	$ -9.19M
Investing Cash Flow	$ 0.00	$ 1.06M	$ -19.00K	$ -112.00K	$ -12.04M
Financing Cash Flow	$ 4.62M	$ 1.50M	$ 1.91M	$ 4.63M	$ 16.79M

Currency in USD

NovaBay Pharma Earnings and Revenue History

Income Statement >

NovaBay Pharma Debt to Assets

Balance Sheet >

NovaBay Pharma Cash Flow

Cash Flow >

NovaBay Pharma Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >